Catalyst Wire Dossier Catalyst Wire Dossier

Mepolizumab (Nucala)

mepolizumab · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Mepolizumab (Nucala), covering 2025-01-14 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Mepolizumab and Physical Activity in Severe Asthma

See pricing